Therefore, activation of N-WASP in skeletal muscle might improve muscle function in patients with centronuclear myopathy, myotonic dystrophy, and other multiple muscle disorders characterized by defects in nuclear positioning and triad organization (Cowling et al, 2012). The gene discussed is WASL; the disease is autosomal dominant centronuclear myopathy.